Persistence Market Research Company
Customize Now Get FREE Sample

Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by Product (Eylea, Lucentis, Beovu, Vabysmo, and Others), by Application (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Myopic Choroidal Neovascularization, and Others), by End User (Hospitals, Ophthalmology Centers, Ambulatory Surgical Centers (ASCs), and Others), and Regional Analysis from 2026 to 2033.

ID: PMRREP33243| 250 Pages | 23 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Recent Product Launches
    3. Regulatory Landscape
    4. Value Chain Analysis
    5. Key Deals and Mergers
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Price Trend Analysis, 2020 - 2033
    1. Key Highlights
    2. Key Factors Impacting Product Prices
    3. Pricing Analysis, By Product
    4. Regional Prices and Product Preferences
  5. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
    3. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis and Volume (Units) Analysis, By Product, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 – 2033
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      4. Market Attractiveness Analysis: By Product
    4. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook: Disease
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Disease, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Disease, 2026 – 2033
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
        6. Others
      4. Market Attractiveness Analysis: Disease
    5. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
        1. Hospitals
        2. Ophthalmology Centers
        3. Ambulatory Surgical Centers (ASCs)
        4. Others
      4. Market Attractiveness Analysis: End User
  6. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 – 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Disease
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis  and Forecast, By Product, 2026 – 2033
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease, 2026 – 2033
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Ophthalmology Centers
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
    7. Market Attractiveness Analysis
  8. Europe Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Disease
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis  and Forecast, By Product, 2026 – 2033
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease, 2026 – 2033
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Ophthalmology Centers
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
    7. Market Attractiveness Analysis
  9. East Asia Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Disease
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 – 2033
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease, 2026 – 2033
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Ophthalmology Centers
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Disease
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis  and Forecast, By Product, 2026 – 2033
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease, 2026 – 2033
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Ophthalmology Centers
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
    7. Market Attractiveness Analysis
  11. Latin America Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Disease
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 – 2033
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease, 2026 – 2033
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
      6. Others
    6.  Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Ophthalmology Centers
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
    7. Market Attractiveness Analysis
  12. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Disease
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 – 2033
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease, 2026 – 2033
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Ophthalmology Centers
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    2. Company Profiles (Details – Overview, Recent Developments)
      1. Regeneron Pharmaceuticals, Inc.
        1. Overview
        2. Segments and Product & End User
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Bayer AG
      3. Novartis AG
      4. F. Hoffmann-La Roche Ltd.
      5. Biogen
      6. Pfizer, Inc.
      7. Coherus BioSciences, Inc.
      8. Amgen, Inc.
      9. Bausch Health Companies, Inc.
      10. Viatris, Inc.
      11. Biogen
      12. Others
  14. Appendix
      1. Research Methodology
      2. Research Assumptions
      3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate